Zhong Yuan Bio-Technology, operating through its subsidiary Bao Feng Bio-Technology, develops and sells nervonic acid-based dietary supplements in China. Nervonic acid is an omega-9 fatty acid that supports myelin synthesis in the brain and nervous system. Bao Feng extracts nervonic acid from the seeds of Acer truncatum maple trees and sells its products under the "Muzhiyuan-Neuro Enhancer" brand, targeting elderly consumers concerned about cognitive decline, parents of children with developmental challenges, and those recovering from neurological conditions. Core products include seed oil capsules, gel candy supplements, a blended cooking oil, and a functional drink line called Re'Seen. Bao Feng sells through a direct sales force, e-commerce channels (WeChat, TikTok, and Alibaba), and roughly 55 domestic distributors. Bao Feng outsources manufacturing to contract producers in Inner Mongolia and Shandong Province, keeping its model asset-light. A key input advantage is its exclusive purchase agreement with a government farm maintaining approximately 70,000 mu of century-old Acer truncatum trees, which produce higher nervonic acid concentrations than younger plantings used by competitors. Beyond supplements, Bao Feng generates smaller revenue from R&D services, patent royalties, and event organization. The company is also developing pre-commercial diagnostic kits for neurological diseases and a pharmaceutical drug targeting Adrenoleukodystrophy, with Phase III trials targeted for mid-2027. Bao Feng holds 20 Chinese invention patents and 2 U.S. utility patents, and aims to expand its portfolio to over 100 patents within five years.